Search - tctmd.com

Displaying 41 - 60 of 316

Sort: Relevancy | Date

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

Yael L. Maxwell

June 17, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Yael L. Maxwell

June 05, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Conference News ACC 2024

BE ACTIVE: Gaming for Points and Money Can Boost Step Counts

L.A. McKeown

April 11, 2024

News Conference News ACC 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

L.A. McKeown

April 04, 2024

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Caitlin E. Cox

December 06, 2023

Advertisement

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

AHA Celebrates a Century by Looking Back, and Forward

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

BE ACTIVE: Gaming for Points and Money Can Boost Step Counts

Faster CAC Progression After Menopause May Warrant Intensified Therapy

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

March 2024 Dispatch for the CV Team

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Less Is More: Lp(a) Much More Atherogenic Than LDL

Top General Cardiology and CVD Prevention News of 2023

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content